RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.

Add to Collection
2017 Sep-Oct Others A Kadakol, V Malek, SK Goru, A Pandey… - Indian Journal of …, 2017 - ncbi.nlm.nih.gov

Full Author : ['Kadakol, Almesh', 'Malek, Vajir', 'Goru, Santosh Kumar', 'Pandey, Anuradha', 'Gaikwad, Anil Bhanudas']
Journal Title : Indian journal of pharmacology
Chapter : Section3
Journal Year : 2017
Cited by : 12.0

OBJECTIVES: Although cardioprotective effects of telmisartan are well explored, its effects on epigenetic alterations associated with type 2 diabetic (T2D) cardiomyopathy remain unmapped. Thus, the present study was designed to evaluate the potential of e..... Read More

Keywords : ["esculetin combination ameliorate type diabetic cardiomyopathy", "histone modification", "telmisartan", "reversal"]
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830845/
Google Scholar Link : https://scholar.google.com/scholar?cites=7770153013945561606&as_sdt=8000005&sciodt=0,19&hl=en&num=20